Clinical Trial Update: Progression of Cognitive and Physical Symptoms in Multiple Sclerosis

View source ↗

Summary

The clinical trial NCT00922831 evaluating progression of cognitive and physical symptoms in multiple sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute | Conditions: Multiple Sclerosis | Status: WITHDRAWN